Harold A. Jenkins III brings more than 28 years of leadership experience.
Customizable, patient-scale cell therapy platform aims to streamline manufacturing to improve process efficiency and reliability.
Finalizes the site's long-term supply agreement with Elanco Animal Health.
Access to Krios and Glacios microscopes allows researchers from both institutions to combine resources to bring more speed and power to their research.
Novel formulation of glycopyrrolate will use Catalent’s Zydis ODT delivery technology for adjunctive therapy for the treatment of peptic ulcer.
New 3PL Division, to begin serving clients in early 2022, will be based at the company’s Cookeville, TN, campus.
Anshul Gupte will be responsible for technical and scientific oversight of client projects, reporting to John Ross, President of Metrics Contract Services.
Fiona Barry of PharmSource discusses COVID vaccines in development and CMO outsourcing trends.
Site in Shawnee, KS to become a global center of excellence serving the pharmaceutical contract development and manufacturing market.
Adds 3,760 square feet of production space and new equipment.
Plans to facilitate accelerated access to high-quality iPSC banks with integrated solutions from plasmid DNA manufacturing to clinical supply.
To address the growing demand for high-quality and advanced containment systems, as well as small and medium-sized batches.
Integrating technology platforms aims to provide sponsors and CROs with a full range of tools designed to reduce the risk of trial delays.